GENB

Generate BiomedicinesC

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-21

View Chart

Peers tracked

U.S. public peers

Grade Position

In line

vs peer average

GENB vs peer average

56/100

GENB vs. peer average (C vs. C)

Grade spread

A 1 · C 5 · D 4 · F 1

Graded peers loaded

Coverage

11 graded

100% of tracked

Peer overview

AGIO is the first available peer comparator.

Clinical-stage biotech peer with valuation driven by pipeline execution and milestone timing rather than current earnings power; useful for comparing how investors price binary development progress.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerAGIOAgios

GENB

Generate Biomedicines

AGIO

Agios

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Mixed

Defensive

Open Side-by-Side Comparison Compare all

Grade position vs AGIO

GENB / AGIO

Grade Position

In line

GENB vs. peer average (C vs. C)

56/100

Momentum

AGIO

Value

GENB

Sentiment

GENB

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs GENB

AGIO

40/100

OCUL

60/100

Even

PVLA

60/100

Even

BCAX

Bicara Therapeutics Inc Common

100/100

-2

MRVI

Maravai Lifesciences Holdings Inc Class A Common

40/100

AGIO is the first peer returned for this comparison set.